Cecilia Vial

2.1k total citations
52 papers, 1.2k citations indexed

About

Cecilia Vial is a scholar working on Infectious Diseases, Molecular Biology and Genetics. According to data from OpenAlex, Cecilia Vial has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 10 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Cecilia Vial's work include Viral Infections and Vectors (14 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and COVID-19 Clinical Research Studies (9 papers). Cecilia Vial is often cited by papers focused on Viral Infections and Vectors (14 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and COVID-19 Clinical Research Studies (9 papers). Cecilia Vial collaborates with scholars based in Chile, United States and France. Cecilia Vial's co-authors include Enrique Brandan, Claudio Cabello‐Verrugio, Daniel Cabrera, Gabriela M. Repetto, Lidia M. Zúñiga, Pablo Vial, Jaime Gutiérrez, Grégory Mertz, S. Eyheramendy and Marcela Ferrés and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Cecilia Vial

50 papers receiving 1.1k citations

Peers

Cecilia Vial
Monica S. Thakar United States
Peter Gerke Germany
Kyung‐Duk Min South Korea
Andrew Kent United States
Anthony King United Kingdom
Christine L. Curry United States
Monica S. Thakar United States
Cecilia Vial
Citations per year, relative to Cecilia Vial Cecilia Vial (= 1×) peers Monica S. Thakar

Countries citing papers authored by Cecilia Vial

Since Specialization
Citations

This map shows the geographic impact of Cecilia Vial's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Vial with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Vial more than expected).

Fields of papers citing papers by Cecilia Vial

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Vial. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Vial. The network helps show where Cecilia Vial may publish in the future.

Co-authorship network of co-authors of Cecilia Vial

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Vial. A scholar is included among the top collaborators of Cecilia Vial based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Vial. Cecilia Vial is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barrera, Aldo, Constanza Martínez-Valdebenito, Jenniffer Angulo, et al.. (2024). SARS-CoV-2 infectivity and antigenic evasion: spotlight on isolated Omicron sub-lineages. Frontiers in Medicine. 11. 1414331–1414331. 2 indexed citations
2.
Poli, M. Cecilia, Cecilia Vial, Emma Rey-Jurado, et al.. (2023). A Third Dose of SARS-CoV-2 mRNA Vaccine Improves Immune Response in Chronic Kidney Disease Patients. Vaccines. 11(5). 1012–1012. 3 indexed citations
3.
Ramírez-Santana, Muriel, Cecilia Vial, Mauricio Apablaza, et al.. (2023). Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022. Viruses. 15(1). 201–201. 7 indexed citations
5.
Apablaza, Mauricio, Cecilia Vial, Jimena Cortés, et al.. (2023). Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study. Vaccine X. 15. 100372–100372. 1 indexed citations
7.
Aguilera, Ximena, Cecilia Vial, Jimena Cortés, et al.. (2022). SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes. Vaccines. 10(7). 1051–1051. 5 indexed citations
8.
Aguilera, Ximena, Mauricio Apablaza, Gloria Icaza, et al.. (2022). Immunization and SARS-CoV-2 Antibody Seroprevalence in a Country with High Vaccination Coverage: Lessons from Chile. Vaccines. 10(7). 1002–1002. 10 indexed citations
9.
Vial, Cecilia, Juan F. Calderón, & Andrés D. Klein. (2020). NPC1 as a Modulator of Disease Severity and Viral Entry of SARSCoV- 2. Current Molecular Medicine. 21(1). 2–4. 9 indexed citations
11.
Eyheramendy, S., et al.. (2015). Genetic structure characterization of Chileans reflects historical immigration patterns. Nature Communications. 6(1). 6472–6472. 92 indexed citations
12.
Repetto, Gabriela M., Iris Delgado, Hugo Loyola, et al.. (2014). Case fatality rate and associated factors in patients with 22q11 microdeletion syndrome: a retrospective cohort study. BMJ Open. 4(11). e005041–e005041. 43 indexed citations
13.
Lay‐Son, Guillermo, et al.. (2014). Chromosomal microarrays testing in children with developmental disabilities and congenital anomalies. Jornal de Pediatria. 91(2). 189–195. 12 indexed citations
14.
Rollán, Antonio, et al.. (2012). Diagnóstico de intolerancia a la lactosa en adultos: rendimiento comparativo de la clínica, test de hidrógeno espirado y test genético. Revista médica de Chile. 140(9). 1101–1108. 5 indexed citations
15.
Poisson, Alice, Paul Krack, Stéphane Thobois, et al.. (2012). History of the ‘geste antagoniste’ sign in cervical dystonia. Journal of Neurology. 259(8). 1580–1584. 31 indexed citations
16.
Nguyen, Tri Q., Peggy Roestenberg, Frans A. van Nieuwenhoven, et al.. (2008). CTGF Inhibits BMP-7 Signaling in Diabetic Nephropathy. Journal of the American Society of Nephrology. 19(11). 2098–2107. 112 indexed citations
17.
Brandan, Enrique, Claudio Cabello‐Verrugio, & Cecilia Vial. (2008). Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy. Matrix Biology. 27(8). 700–708. 79 indexed citations
18.
Mezzano, Valeria, Daniel Cabrera, Cecilia Vial, & Enrique Brandan. (2007). Constitutively activated dystrophic muscle fibroblasts show a paradoxical response to TGF-β and CTGF/CCN2. Journal of Cell Communication and Signaling. 1(3-4). 205–217. 41 indexed citations
19.
Vial, Cecilia, Lidia M. Zúñiga, Claudio Cabello‐Verrugio, et al.. (2007). Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF/CCN2), which induces their dedifferentiation. Journal of Cellular Physiology. 215(2). 410–421. 106 indexed citations
20.
Bady, B, André Truffert, G Chauplannaz, et al.. (1992). Données électrophysiologiques dans les syndromes myasthéniformes de type Lambert-Eaton. À propos d'une série de 23 cas. Neurophysiologie Clinique. 22(1). 27–39. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026